Overview
- 117 inspections across 113 sites are on record.
- 98 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-22.
At a glance
Inspections
117
Sites
113
Observations
98
Career since
Oct 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Suneel D. Kamath, MD | 22 May 2026 | Human Drugs | |
| Aaron D. Friedman, MD | 12 May 2026 | Biologics | |
| TWi Pharmaceuticals Inc. | 27 Mar 2026 | Human Drugs | |
| Shanghai InnoStar Bio-tech Co., Ltd. | 20 Mar 2026 | Human Drugs | On file |
| Suzhou Frontage New Drug Development Co., Ltd. | 13 Mar 2026 | Human Drugs | On file |
Sites inspected
Suneel D. Kamath, MDCleveland, United States1 insp.
Aaron D. Friedman, MDCincinnati, United States1 insp.
TWi Pharmaceuticals Inc.Taipei City, Taiwan1 insp.
Shanghai InnoStar Bio-tech Co., Ltd.Pu Dongxin District, China1 insp.
Suzhou Frontage New Drug Development Co., Ltd.Suzhou, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Marcia A Worley8 shared
Richard W Berning6 shared
Erin M Mcdowell5 shared
Andrew M Kupper4 shared
D'Arbra R Blankenship3 shared
Yvette M Lacour-Davis3 shared
Craig P Seaborn3 shared
Zhou Chen2 shared
Karen M Montgomery2 shared
Jonathan D Green2 shared
Full investigator report
Get the verbatim findings behind Kathryn Suttling's 98 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site